Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Twin molar pregnancy: a diagnostic framework for early recognition and appropriate management.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·2026
Same author

Checkpoint Inhibition in Gestational Trophoblastic Neoplasia: A Narrative Review on the Reawakening of Antitumor Immunity.

Advances in therapy·2026
Same author

Home-based treatment of low-risk gestational trophoblastic neoplasia with 8-day methotrexate/folinic acid.

Gynecologic oncology·2025
Same author

Phenotypic Alteration and Suppression of Cytotoxicity of Decidual NK Cells After Co-culturing With Different Trophoblastic Cell Lines.

Anticancer research·2025
Same author

Initial Treatment and Outcomes of Complete Hydatidiform Mole in Women 40 Years or Older: A Multicenter Cohort Study.

Cancers·2025
Same author

Diagnosis and Surgical Treatment of Hydatidiform Mole.

Diagnostics (Basel, Switzerland)·2025
Same journal

Pharmacotherapeutic interventions for pediatric ulcerative colitis.

Expert opinion on pharmacotherapy·2026
Same journal

The rise and fall of TRPV1-targeted analgesia in osteoarthritis: a critical appraisal.

Expert opinion on pharmacotherapy·2026
Same journal

Dopamine transporter and beyond: evolving targets and combination strategies in stimulant use disorder.

Expert opinion on pharmacotherapy·2026
Same journal

GnRH antagonists for the treatment of fibroids and adenomyosis, current evidence and future perspectives.

Expert opinion on pharmacotherapy·2026
Same journal

Pharmacotherapeutic strategies for the management of congenital adrenal hyperplasia.

Expert opinion on pharmacotherapy·2026
Same journal

Current advances in pharmacotherapeutic strategies for the treatment of complicated intra-abdominal infections.

Expert opinion on pharmacotherapy·2026
See all related articles

Related Experiment Video

Updated: Jun 7, 2026

Trophoblast Cell Recovery from Angiogenesis-Tube Formation Assay for Differentiation Marker Expression Analysis
05:30

Trophoblast Cell Recovery from Angiogenesis-Tube Formation Assay for Differentiation Marker Expression Analysis

Published on: November 8, 2024

Treating gestational trophoblastic disease.

Noah Rodriguez1, Donald P Goldstein, Ross S Berkowitz

  • 1Brigham and Women's Hospital/Dana Farber Cancer Institute, Department of Obstetrics and Gynecology, New England Trophoblastic Disease Center, Harvard Medical School, Boston, MA 02115, USA.

Expert Opinion on Pharmacotherapy
|October 21, 2010
PubMed
Summary
This summary is machine-generated.

Gestational trophoblastic neoplasia (GTN) is a curable malignancy. Effective management, including chemotherapy and selective surgery, ensures high cure rates and preserves fertility, even in advanced or recurrent cases.

Related Experiment Videos

Last Updated: Jun 7, 2026

Trophoblast Cell Recovery from Angiogenesis-Tube Formation Assay for Differentiation Marker Expression Analysis
05:30

Trophoblast Cell Recovery from Angiogenesis-Tube Formation Assay for Differentiation Marker Expression Analysis

Published on: November 8, 2024

Area of Science:

  • Gynecology
  • Oncology

Background:

  • Gestational trophoblastic disease (GTD) is a rare but curable human malignancy.
  • Proper management and follow-up are critical for successful treatment outcomes.

Purpose of the Study:

  • To provide a comprehensive review of current and emerging treatment strategies for GTD.
  • To guide the classification and management of GTD into risk-stratified groups.

Main Methods:

  • Analysis of observational, retrospective, and prospective studies on GTD management.
  • Literature search of PubMed, Medline, and Library of Congress databases (1965-2010).

Main Results:

  • Information on classifying GTD into low- and high-risk categories.
  • Details on medical and surgical management for low-risk, high-risk, and recurrent GTD.
  • Review of treatment efficacy and impact on fertility.

Conclusions:

  • GTN demonstrates high responsiveness to chemotherapy.
  • Surgery serves as a crucial adjunct in specific GTD cases.
  • Cure and fertility preservation are achievable even in advanced or recurrent GTN.